Immunocore Holdings(DE:6YG)
€28.20-0.60 (-2.08%)
DE:6YG
Immunocore Holdings financials statements
€28.20
At close:-0.60 (-2.08%)
Immunocore Holdings (6YG) Income Statement
0 Followers
Immunocore Holdings Income Statement
Last quarter (Q3 2026), Immunocore Holdings's total revenue was £102.22M, a decrease of 1.42% from the same quarter last year. In Q3, Immunocore Holdings's net income was £-14.22M. See Immunocore Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| £ 400.02M | £ 310.48M | £ 197.39M | £ 144.23M | £ 27.04M | |
| £ 391.66M | £ 303.54M | £ 196.57M | £ 138.94M | £ 27.04M | |
| £ 437.02M | £ 374.07M | £ 243.77M | £ 181.71M | £ 156.46M | |
| Depreciation and Amortization | £ 3.27M | £ 5.26M | £ 3.24M | ― | ― |
| £ 520.00K | £ -47.15M | £ -40.87M | ― | ― | |
| £ -45.35M | £ -70.47M | £ -47.20M | £ -42.77M | £ -129.42M | |
| £ 26.25M | £ 17.54M | £ -982.07K | £ 8.95M | £ -3.92M | |
| £ -19.10M | £ -52.98M | £ -48.19M | £ -33.82M | £ -133.34M | |
| £ -35.51M | £ -51.09M | £ -43.75M | £ -43.46M | £ -133.45M | |
| Per Share Metrics | |||||
| Basic EPS | £ -0.71 | £ -1.02 | £ -0.89 | £ -0.95 | £ -3.13 |
| Diluted EPS | £ -0.71 | £ -1.02 | £ -0.89 | £ -0.95 | £ -3.00 |
| Weighted Average Shares Outstanding | 50.35M | 49.99M | 48.89M | 45.71M | 42.49M |
| Weighted Average Shares Outstanding (Diluted) | 50.35M | 49.99M | 48.89M | 45.71M | 43.86M |
Currency in GBP
